In recent trading session, Boston Scientific Corp. (NYSE:BSX) saw 2.69 million shares changing hands at last check today with its beta currently measuring 0.79. Company’s recent per share price level of $74.97 trading at $0.71 or 0.96% at last check today assigns it a market valuation of $110.22B. That most recent trading price of BSX’s stock is at a discount of -5.95% from its 52-week high price of $79.43 and is indicating a premium of 35.51% from its 52-week low price of $48.35. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 7.76 million shares which gives us an average trading volume of 5.93 million if we extend that period to 3-months.

For Boston Scientific Corp. (BSX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.46. Splitting up the data highlights that, out of 15 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 13 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Boston Scientific Corp. (NYSE:BSX) trade information

Upright in the green today for gaining 0.96%, in the last five days BSX remained trading in the red while hitting it’s week-highest on Tuesday, 07/23/24 when the stock touched $74.97 price level, adding 5.62% to its value on the day. Boston Scientific Corp.’s shares saw a change of 29.68% in year-to-date performance and have moved -3.34% in past 5-day. Boston Scientific Corp. (NYSE:BSX) showed a performance of -2.76% in past 30-days. Number of shares sold short was 11.53 million shares which calculate 2.12 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 77 to the stock, which implies a rise of 2.64% to its recent value today. Analysts have been projecting 48 as a low price target for the stock while placing it at a high target of 118. It follows that stock’s current price would jump 35.97% in reaching the projected high whereas dropping to the targeted low would mean a gain of 35.97% for stock’s current value.

Boston Scientific Corp. (BSX) estimates and forecasts

Statistics highlight that Boston Scientific Corp. is scoring comparatively higher than the scores of other players of the relevant industry. The company added 23.25% of value to its shares in past 6 months, showing an annual growth rate of 16.59% while that of industry is 11.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.05% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 17.09% while estimates for its earnings growth in next 5 years are of 12.40%.

Boston Scientific Corp. (NYSE:BSX)’s Major holders

Insiders are in possession of 0.19% of company’s total shares while institution are holding 92.70 percent of that, with stock having share float percentage of 92.87%. Investors also watch the number of corporate investors in a company very closely, which is 92.70% institutions for Boston Scientific Corp. that are currently holding shares of the company. FMR LLC is the top institutional holder at BSX for having 141.93 million shares of worth $9.72 billion. And as of 2024-03-31, it was holding 9.7681 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 127.44 million shares on 2024-03-31. The number of shares represents firm’s hold over 8.7707 of outstanding shares, having a total worth of $8.73 billion.